Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
WEHI-345 reduces mRNA levels of NF-kB targets such as TNF
Chemical Name: 4-((2R
Adamson PC
The IC50 for AG14361 is 29 nM in permeabilized SW620 cells and 14 nM in intact SW620 cells
MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat
Idebenone Catalog No.:M9526-2 WEHI-345 reduces mRNA levels ofIdebenone, also known as CV 2619, ss a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. As of December 2013 the drug is not approved for these indications in North America or Europe, but it is approved for the treatment of Leber's hereditary optic neuropathy (LHON) in Europe. Product information CAS Number: 58186 27 9 Molecular Weight: 338. 44 Formula: C19H30O5
US$ 26.95
US$ 46.95
US$ 162.50
US$ 56.95
US$ 46.95
US$ 26.95
US$ 56.95
US$ 24.95
US$ 26.95